Authors: Para, MF Glidden, DV Coombs, RW Collier, AC Condra, JH Craig, C Bassett, R Leavitt, R Snyder, S McAuliffe, V Boucher, C

Citation: Mf. Para et al., Baseline human immunodeficiency virus type 1 phenotype, genotype, and RNA response after switching from long-term hard-capsule saquinavir to indinavir or soft-gel-capsule saquinavir in AIDS Clinical Trials Group protocol 333, J INFEC DIS, 182(3), 2000, pp. 733-743

Authors: Gulick, RM McAuliffe, V Holden-Wiltse, J Crumpacker, C Liebes, L Stein, DS Meehan, P Hussey, S Forcht, J Valentine, FT

Citation: Rm. Gulick et al., Phase I studies of hypericin, the active compound in St. John's Wort, as an antiretroviral agent in HIV-infected adults - AIDS clinical trials group protocols 150 and 258, ANN INT MED, 130(6), 1999, pp. 510-514